Clindamycin is widely prescribed for its ability to treat a number of common bacterial infections. Thus, clindamycin enters wastewater via human excretion or disposal of unused medication and widespread detection of pharmaceuticals in rivers proves the insufficiency of conventional wastewater treatment plants in removing clindamycin. Recently, it has been discovered that attached biofilm reactors, e.g., moving bed biofilm reactors (MBBRs) obtain a higher removal of pharmaceuticals than conventional sludge wastewater treatment plants. Therefore, this study investigated the capability of MBBRs applied in the effluent of conventional wastewater treatment plants to remove clindamycin. First, a batch experiment was executed with a high initial concentration of clindamycin to identify the transformation products. It was shown that clindamycin can be removed from wastewater by MBBR and the treatment process converts clindamycin into the, possibly persistent, products clindamycin sulfoxide and N-desmethyl clindamycin as well as 3 other mono-oxygenated products. Subsequently, the removal kinetics of clindamycin and the formation of the two identified products were investigated in batch experiments using MBBR carriers from polishing and nitrifying reactors. Additionally, the presence of these two metabolites in biofilm-free wastewater effluent was studied. The nitrifying biofilm reactor had a higher biological activity with k-value of 0.1813 h than the reactor with polishing biofilm (k = 0.0161 h) which again has a much higher biological activity for removal of clindamycin than of the suspended bacteria (biofilm-free control). Clindamycin sulfoxide was the main transformation product which was found in concentrations exceeding 10% of the initial clindamycin concentration after 1 day of MBBR treatment. Thus, MBBRs should not necessarily be considered as reactors mineralizing clindamycin as they perform transformation reactions at least to some extent.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.watres.2017.01.058 | DOI Listing |
BMC Oral Health
March 2025
Department of Microbiology and Immunology, Faculty of Medicine, Al-Quds University, Jerusalem, Palestine.
Background: The nose is the primary colonization site of S. aureus which is a known risk factor for causing S. aureus infection.
View Article and Find Full Text PDFMedicine (Baltimore)
March 2025
Department of Emergency, Jiangnan University Medical Center, JUMC, Wuxi, Jiangsu Province, China.
Septic acute respiratory distress syndrome (ARDS) is a complex and noteworthy type, but its molecular mechanism has not been fully elucidated. The aim is to explore specific biomarkers to diagnose sepsis-induced ARDS. Gene expression data of sepsis alone and sepsis-induced ARDS were downloaded from public databases, and the differential immune cells and differential expressed genes between the 2 groups were screened.
View Article and Find Full Text PDFHeliyon
February 2025
Departamento de Patobiología, Facultad de Veterinaria, Universidad de La República, Uruguay.
Bovine mastitis, a prevalent disease, is often attributed to staphylococci species. These microorganisms can express a diverse array of virulence genes and have the capability to form biofilms, establishing a robust defense against antimicrobials and host immune responses. In this study, we analyzed 191 spp.
View Article and Find Full Text PDFSurg Infect (Larchmt)
March 2025
Department of Anesthesiology and Intensive Care Medicine, Kliniken Maria Hilf, Mönchengladbach, Germany.
Anastomotic leaks after esophagectomy cause significant morbidity and mortality. In addition to their early detection and prompt endoscopic or surgical management, providing adequate antimicrobial agents is a fundamental aspect of therapy. In this study, different types of microbiological samples were analyzed to provide insight into the microbial pathogen spectrum of anastomotic leaks after esophagectomy.
View Article and Find Full Text PDFNat Chem
March 2025
Department of Chemistry and Chemical Biology, Harvard University, Cambridge, MA, USA.
The emergence of bacterial antimicrobial resistance threatens to undermine the utility of antibiotic therapy in medicine. This threat can be addressed, in part, by reinventing existing antibiotic classes using chemical synthesis. Here we present the discovery of BT-33, a fluorinated macrobicyclic oxepanoprolinamide antibiotic with broad-spectrum activity against multidrug-resistant bacterial pathogens.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!